1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Infliximab and adalimumab for the treatment of Crohn's disease

Technology appraisal guidance [TA187] Published: 19 May 2010

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Review decision  
  • Review decision – February 2018  
  • Review decision paper PDF 316 KB 28 February 2018